PT93716A - Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo - Google Patents

Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo

Info

Publication number
PT93716A
PT93716A PT93716A PT9371690A PT93716A PT 93716 A PT93716 A PT 93716A PT 93716 A PT93716 A PT 93716A PT 9371690 A PT9371690 A PT 9371690A PT 93716 A PT93716 A PT 93716A
Authority
PT
Portugal
Prior art keywords
dissulfuret
antitumers
antibacterials
tritium
methyl
Prior art date
Application number
PT93716A
Other languages
English (en)
Other versions
PT93716B (pt
Inventor
George A Ellestad
William James Mcgahren
Martin Leon Sassiver
Philip R Hamann
Lois M Himann
Janis Upeslacis
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/339,343 external-priority patent/US5053394A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PT93716A publication Critical patent/PT93716A/pt
Publication of PT93716B publication Critical patent/PT93716B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Engine Equipment That Uses Special Cycles (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Lubricants (AREA)
  • Treating Waste Gases (AREA)
PT93716A 1989-04-14 1990-04-10 Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo PT93716B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33932389A 1989-04-14 1989-04-14
US07/339,343 US5053394A (en) 1988-09-21 1989-04-14 Targeted forms of methyltrithio antitumor agents

Publications (2)

Publication Number Publication Date
PT93716A true PT93716A (pt) 1990-11-20
PT93716B PT93716B (pt) 1996-08-30

Family

ID=26991573

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93716A PT93716B (pt) 1989-04-14 1990-04-10 Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo

Country Status (16)

Country Link
EP (1) EP0392384B1 (pt)
JP (1) JP2951684B2 (pt)
CN (2) CN1046333A (pt)
AT (1) ATE163293T1 (pt)
AU (1) AU633069B2 (pt)
CZ (1) CZ293228B6 (pt)
DE (1) DE69032051T2 (pt)
DK (1) DK0392384T3 (pt)
ES (1) ES2112244T3 (pt)
FI (1) FI100105B (pt)
GR (1) GR3026177T3 (pt)
IL (3) IL115770A (pt)
NO (2) NO176717C (pt)
NZ (1) NZ233148A (pt)
PT (1) PT93716B (pt)
SK (1) SK284270B6 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2
GB9120467D0 (en) * 1991-09-26 1991-11-06 Celltech Ltd Anti-hmfg antibodies and process for their production
US6015562A (en) * 1992-09-22 2000-01-18 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5773001A (en) * 1994-06-03 1998-06-30 American Cyanamid Company Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US6441163B1 (en) * 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
DK3066074T3 (da) * 2013-11-04 2020-02-10 Pfizer Mellemprodukter og fremgangsmåder til syntetisering af calicheamicin-derivater
MA45326A (fr) 2015-10-20 2018-08-29 Genentech Inc Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
JP6917049B2 (ja) * 2017-02-22 2021-08-11 公立大学法人大阪 特定のサルファイド化合物に結合する抗体及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1215212A3 (en) * 1987-01-30 2003-05-21 Wyeth Holdings Corporation Dihydro derivatives of LL-E33288 antibiotics
ATE112172T1 (de) * 1987-10-30 1994-10-15 American Cyanamid Co Targetformer von antitumor-methyltrithioagenzien.

Also Published As

Publication number Publication date
CZ293228B6 (cs) 2004-03-17
EP0392384B1 (en) 1998-02-18
EP0392384A3 (en) 1991-11-06
NO176717C (no) 1995-05-16
NO901655L (no) 1990-10-15
EP0392384A2 (en) 1990-10-17
AU5324190A (en) 1990-11-01
CN1110280A (zh) 1995-10-18
JP2951684B2 (ja) 1999-09-20
GR3026177T3 (en) 1998-05-29
DE69032051D1 (de) 1998-03-26
IL93733A0 (en) 1990-12-23
IL93733A (en) 1996-01-19
FI901866A0 (fi) 1990-04-12
IL115770A (en) 1999-03-12
NO177308B (no) 1995-05-15
NO932192L (no) 1990-10-15
NO932192D0 (no) 1993-06-14
ATE163293T1 (de) 1998-03-15
FI100105B (fi) 1997-09-30
NZ233148A (en) 1996-02-27
AU633069B2 (en) 1993-01-21
NO177308C (no) 1995-08-23
DK0392384T3 (da) 1998-03-16
NO176717B (no) 1995-02-06
NO901655D0 (no) 1990-04-11
JPH02292294A (ja) 1990-12-03
DE69032051T2 (de) 1998-06-10
ES2112244T3 (es) 1998-04-01
CN1109041C (zh) 2003-05-21
SK284270B6 (sk) 2004-12-01
SK188490A3 (en) 2000-08-16
CN1046333A (zh) 1990-10-24
PT93716B (pt) 1996-08-30
CZ188490A3 (cs) 2000-08-16
IL115770A0 (en) 1996-01-19

Similar Documents

Publication Publication Date Title
PT94059A (pt) Processo para a preparacao de copolimetros hidrossoluveis, de n-vinilamidas
PT93716A (pt) Processo para a preparacao de derivados dissulfureto substituido antitumores e antibacterianos a partir de compostos que processam um grupo metil-tritio e suas formas alvo
PT94226A (pt) Processo de preparacao de 1,2-dioxetanos que produzem quimioluminescencia por activacao dupla
PT90569A (pt) Processo para a preparacao de 2-piperazinil- ou 2-homopiperazinil-1,2,3,4-tetra-hidronaftalenos
PT91302A (pt) Processo para a preparacao de composicoes farmaceuticas contendo imidazo {2,1-a} isoquinolinas substituidas por 5-heteroarilo ou 5-arilo
BR9004539A (pt) Processo para a obtencao de 1,1,1,2-tetrafluoretano
FI951377A (fi) N-asetyylineuramiinihappojohdannaisten synteesi
PT87946A (pt) Processo para a preparacao de derivados 4-amino susbtituido-1,2-dihidroxinaftaleno
PT93736A (pt) Processo para a preparacao de n,n'-ditrimetoxi-benzoil-piperazinas 2- substituidas
BR9003360A (pt) Processo para a obtencao de 1,1,1-trifluor-2-cloroetano
PT90212A (pt) Processo aperfeicoado para a preparacao de derivados de 3-fenoloxi-3-fenil-propanaminas
BR9206468A (pt) Processo para produzir solução aquosa de ácido hipocloroso.
ES2028834T3 (es) Metodo para la preparacion de accidos piridin-2,3-dicarboxilico.
BR8801214A (pt) Processo para a producao de um composto azoico hidrossoluvel,processo para o tingimento(inclusive estampagem)de material contendo grupos hidroxi e/ou carbonamida,e processo para a producao de compostos intermediarios par o dito composto azoico
PT94480A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de isoxazolin-3-ona uteis como antidepressivos
BR9007499A (pt) Processo para a preparacao de 2,4,6-trifluor-1,3,5-triazina
PT95518A (pt) Processo para a preparacao de 3-aroil-2-oxindole-1-carboxamidas
BR9404216A (pt) Processo para a preparação de tetracloro-1,4-benzoquinona
PT88952A (pt) Processo para a preparacao de avermectinas etiladas
BR8305272A (pt) Composto de 1,2,3,4-tetra-hidro-1-aminometil-4-fenil-isoquinolina e processo de preparacao
BR9305542A (pt) Processo para a preparação de 5-alcóxi-2,4-dinitro-alquilbenzenos
BR8800498A (pt) Derivado de benzil-ureia,processo para sua producao composicao inseticida processo para controlar ou exterminar insetos e/ou acaros,e composto de 4-anilino-anilina
BR8801947A (pt) Processo para a preparacao de 3-cloro-4,5-difluorobenzotrifluoreto
BR8707521A (pt) Processo para producao de fenol substituido por grupo alcoxialquila
BR9000478A (pt) Processo para obtencao de 3,4,5,6-tetrahidroftalimidas n-substituidas

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960529

PD3A Change of proprietorship

Free format text: WYETH HOLDINGS CORPORATION US

Effective date: 20031117

TE3A Change of address (patent)

Free format text: AMERICAN CYANAMID COMPANY US

Effective date: 20031117

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20110530